Virtus Advisers LLC acquired a new position in Chemed Corporation (NYSE:CHE – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,017 shares of the company’s stock, valued at approximately $474,000.
Other large investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Chemed by 2,444,879.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Chemed during the second quarter worth approximately $691,290,000. JPMorgan Chase & Co. raised its stake in Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after purchasing an additional 21,932 shares during the last quarter. AQR Capital Management LLC raised its stake in Chemed by 89.2% in the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after purchasing an additional 153,469 shares during the last quarter. Finally, TD Asset Management Inc lifted its holdings in Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Chemed Stock Performance
Shares of Chemed stock opened at $534.93 on Friday. The business’s 50 day moving average price is $496.79 and its 200 day moving average price is $445.76. The company has a market cap of $6.99 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 2.03 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00.
Chemed Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date is Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is 14.06%.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on CHE. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $530.75.
Check Out Our Latest Stock Report on Chemed
Insider Buying and Selling
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 3,537 shares of company stock worth $1,782,654. Insiders own 3.33% of the company’s stock.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Stories
- Five stocks we like better than Chemed
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
